Incidence of metabolic syndrome and relative importance of five components as a predictor of metabolic syndrome: 5-year follow-up study in Korea

Journal of Korean Medical Science

Volumn 28, Issue 12, 2013, Pages 1768-1773

  Hwang, Jun Hyun ^a   Kam, Sin ^b   Shin, Ji Yeon ^c   Kim, Jong Yeon ^a   Lee, Kyung Eun ^b   Kwon, Gi Hong ^d   Chun, Byung Yeol ^b   Chae, Shung Chull ^e   Yang, Dong Heon ^e   Park, Hun Sik ^e   Hwang, Tae Yoon ^f  

^a Catholic University of Daegu   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c National Cancer Center   (South Korea)

^d Yeungnam College of Science and Technology   (South Korea)

^e Kyungpook National University Hospital   (South Korea)

^f Yeungnam University College of Medicine   (South Korea)

Author keywords

Cohort studies; Incidence; Metabolic syndrome; Risk factors

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BLOOD; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SOUTH KOREA;

COHORT STUDIES; INCIDENCE; METABOLIC SYNDROME; RISK FACTORS;

ADULT; AGED; CHOLESTEROL, HDL; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY, ABDOMINAL; REPUBLIC OF KOREA; RISK FACTORS;

EID: 84900435832     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2013.28.12.1768     Document Type: Article

References (29)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-28.
2. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-7.
3. Lee MG, Jeong MH, Ahn Y, Chae SC, Hur SH, Hong TJ, Kim YJ, Seong IW, Chae JK, Rhew JY, et al. Impact of the metabolic syndrome on the clinical outcome of patients with acute ST-elevation myocardial infarction. J Korean Med Sci 2010; 25: 1456-61.
4. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-9.
5. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-16.
6. Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among U.. adults: NHANES III to NHANES 1999-2006. Diabetes Care 2011; 34: 216-9.
7. Lim S, Shin H, Song JH, Kwak SH, Kang SM, Won Yoon J, Choi SH, Cho SI, Park KS, Lee HK, et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care 2011; 34: 1323-8.
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
9. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Available at http://www.idf.org/webdata/docs/Metac_syndrome_def.pdf [accessed on 29 November 2012].
10. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome: a new world-wide definition: a Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-80.
11. Szklo M, Nieto FJ. Epidemiology beyond the basics. 2nd ed. Sudbury: Jones & Bartlett Pub, 2005, p68-70.
12. Santos AC, Severo M, Barros H. Incidence and risk factors for the metabolic syndrome in an urban South European population. Prev Med 2010; 50: 99-105.
13. Balkau B, Vernay M, Mhamdi L, Novak M, Arondel D, Vol S, Tichet J, Eschwège E ; D.E.S.I.R. Study Group. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome: the French D.E.S.I.R. Study. Diabetes Metab 2003; 29: 526-32.
14. Carnethon MR, Loria CM, Hill JO, Sidney S, Savage PJ, Liu K; Coronary Artery Risk Development in Young Adults Study. Risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (CARDIA) Study, 1985-2001. Diabetes Care 2004; 27: 2707-15.
15. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22: 11-9.
16. Bener A, Mohammad AG, Ismail AN, Zirie M, Abdullatef WK, Al-Hamaq AO. Gender and age-related differences in patients with the metabolic syndrome in a highly endogamous population. Bosn J Basic Med Sci 2010; 10: 210-7.
17. Weng C, Yuan H, Tang X, Huang Z, Yang K, Chen W, Yang P, Chen Z, Chen F. Age- and gender dependent association between components of metabolic syndrome and subclinical arterial stiffness in a Chinese population. Int J Med Sci 2012; 9: 730-7.
18. Williams CM. Lipid metabolism in women. Proc Nutr Soc 2004; 63: 153-60.
19. Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol 2006; 95: 136-47.
20. Korea National Health and Nutrition Examination Survey. KNHANES statistical information. Available at http://knhanes.cdc.go.kr [accessed on 29 November 2012].
21. Hwang LC, Bai CH, Chen CJ, Chien KL. Gender difference on the development of metabolic syndrome: a population-based study in Taiwan. Eur J Epidemiol 2007; 22: 899-906.
22. Palaniappan L, Carnethon MR, Wang Y, Hanley AJ, Fortmann SP, Haffner SM, Wagenknecht L; Insulin Resistance Atherosclerosis Study. Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study. Diabetes Care 2004; 27: 788-93.
23. Cheung BM, Wat NM, Tam S, Thomas GN, Leung GM, Cheng CH, Woo J, Janus ED, Lau CP, Lam TH, et al. Components of the metabolic syndrome predictive of its development: a 6-year longitudinal study in Hong Kong Chinese. Clin Endocrinol (Oxf) 2008; 68: 730-7.
24. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-94.
25. Anderson PJ, Critchley JA, Chan JC, Cockram CS, Lee ZS, Thomas GN, Tomlinson B. Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. Int J Obes Relat Metab Disord 2001; 25: 1782-8.
26. Goff DC Jr, Zaccaro DJ, Haffner SM, Saad MF; Insulin Resistance Atherosclerosis Study. Insulin sensitivity and the risk of incident hypertension: insights from the Insulin Resistance Atherosclerosis Study. Diabetes Care 2003; 26: 805-9.
27. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992; 41: 715-22.
28. Ryu S, Song J, Choi BY, Lee SJ, Kim WS, Chang Y, Kim DI, Suh BS, Sung KC. Incidence and risk factors for metabolic syndrome in Korean male workers, ages 30 to 39. Ann Epidemiol 2007; 17: 245-52.
29. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive summary. Crit Pathw Cardiol 2005; 4: 198-203.